Hybrid nanoparticles for drug delivery and bioimaging: mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye.

The development of a drug delivery system with fluorescent biolabels is important in anti-cancer drug delivery application due to the potential for simultaneous diagnosis and treatment of diseases. Here, we reported the synthesis and multiple functionalization of mesoporous silica nanoparticle (MSN) for bioimaging and controlled drug release. After the functionalization with carboxyl group, the nanoparticles exhibited much better dispersity and stability in aqueous solution than MSN. Furthermore, a substantial doxorubicin (DOX) loading level was achieved and DOX-loaded nanoparticles exhibited noticeable pH-sensitive behavior with accelerated release of DOX in acidic environment. Compared with native DOX-MSN, DOX-MSN/COOH-Cy5 exhibited enhanced intracellular uptake efficacy and stronger effect on killing tumor cells. Meanwhile, it was observed that the MSN/COOH-Cy5 was able to locate in the cytoplasm of MCF-7 cells and could accumulate in tumor tissues for a long period of time. Overall, the functional nanoparticle could potentially be used for simultaneous controlled drug release and near-infrared fluorescent bioimaging.

[1]  C. Prestidge,et al.  Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids. , 2012, Nanoscale.

[2]  Y. Hung,et al.  Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells , 2009 .

[3]  Xuesi Chen,et al.  Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs). , 2011, Journal of colloid and interface science.

[4]  Christy L Haynes,et al.  Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. , 2010, Journal of the American Chemical Society.

[5]  M. Zachariah,et al.  Mesoscale porous silica as drug delivery vehicles: Synthesis, characterization, and pH-sensitive release profiles , 2011 .

[6]  J. Labis,et al.  Synthesis of double mesoporous core-shell silica spheres with tunable core porosity and their drug release and cancer cell apoptosis properties. , 2012, Journal of colloid and interface science.

[7]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[8]  Hiroaki Sai,et al.  Ultrasmall sub-10 nm near-infrared fluorescent mesoporous silica nanoparticles. , 2012, Journal of the American Chemical Society.

[9]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles for intracellular controlled drug delivery. , 2010, Small.

[10]  M. Vallet‐Regí,et al.  Studies on MCM-41 mesoporous silica for drug delivery: Effect of particle morphology and amine functionalization , 2008 .

[11]  Sunita Yadav,et al.  Multi-functional nanocarriers to overcome tumor drug resistance. , 2008, Cancer treatment reviews.

[12]  J. Eriksson,et al.  Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems. , 2009, Nano letters.

[13]  Kazuko Kobayashi,et al.  Intra‐tumoral injection of doxorubicin (adriamycin) encapsulated in liposome inhibits tumor growth, prolongs survival time and is not associated with local or systemic side effects , 2000, International journal of cancer.

[14]  S. Liao,et al.  A biocompatible drug delivery nanovalve system on the surface of mesoporous nanoparticles , 2012 .

[15]  M. S. Muthu,et al.  Stimulus-responsive targeted nanomicelles for effective cancer therapy. , 2009, Nanomedicine.

[16]  Eugene Shi Guang Choo,et al.  Synthesis of poly(acrylic acid) (PAA) modified Pluronic P123 copolymers for pH-stimulated release of doxorubicin. , 2011, Journal of colloid and interface science.

[17]  Hsiung-Lin Tu,et al.  In vitro Studies of Functionalized Mesoporous Silica Nanoparticles for Photodynamic Therapy , 2009 .

[18]  M. Xie,et al.  Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies , 2012, International journal of nanomedicine.

[19]  W. Fan,et al.  Investigation of polyethylenimine‐grafted‐triamcinolone acetonide as nucleus‐targeting gene delivery systems , 2010, The journal of gene medicine.

[20]  X. Zhao,et al.  Pore size control of mesoporous silicas from mixtures of sodium silicate and TEOS , 2007 .

[21]  Jia Guo,et al.  General one-pot strategy to prepare multifunctional nanocomposites with hydrophilic colloidal nanoparticles core/mesoporous silica shell structure. , 2012, Journal of colloid and interface science.

[22]  Qian Liu,et al.  Comparisons between surfactant-templated mesoporous and conventional sol–gel-derived CaO–B2O3–SiO2 glasses: Compositional, textural and in vitro bioactive properties , 2008 .

[23]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[24]  Xiaoke Zhang,et al.  Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system. , 2012, Journal of colloid and interface science.

[25]  Ick Chan Kwon,et al.  Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Baorui Liu,et al.  Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  Yufang Zhu,et al.  PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles , 2011 .

[28]  Victor S-Y Lin,et al.  Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. , 2006, Journal of the American Chemical Society.

[29]  J. Rosenholm,et al.  Cancer-cell targeting and cell-specific delivery by mesoporous silica nanoparticles , 2010 .

[30]  Chung-Yuan Mou,et al.  Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. , 2009, Small.

[31]  S. Manju,et al.  Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells. , 2012, Journal of colloid and interface science.

[32]  Cecilia Sahlgren,et al.  Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges. , 2010, Nanoscale.

[33]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[34]  Monty Liong,et al.  Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. , 2008, ACS nano.

[35]  J. Panyam,et al.  Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[36]  K. Chennazhi,et al.  Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. , 2011, Journal of colloid and interface science.

[37]  Atsushi Shimojima,et al.  Organic-inorganic mesoporous nanocarriers integrated with biogenic ligands. , 2007, Small.